Biomarkers in Chemotherapy-Induced Peripheral Neurotoxicity

Clinical trial NCT03348956 · COMPLETED

Trial details

NCT number: NCT03348956
Sponsor: Dartmouth-Hitchcock Medical Center
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

CIPN - Chemotherapy-Induced Peripheral Neuropathy

Start date: 2018-03-01
Primary completion: 2022-02-14
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.